University of California, Irvine
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, Irvine sits in the top decile of US sponsors by registered trial count (#96 of 15,742 sponsors by registered trial count).
University of California, Irvine: 368 sponsored US clinical trials, 74 recruiting.
University of California, Irvine sponsors 368 registered US clinical trials on ClinicalTrials.gov, 74 of them currently recruiting, and 228 completed. 27 of these trials are in Phase 3-4 (later-stage) and 92 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cancer, with 6 trials.
Top-decile sponsor footprint
University of California, Irvine ranks in the top decile of sponsors by registered trial count (#96 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
228 of 258 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
368 total, page 5 of 8
Randomization of Botox for Stent Pain and Irritative Voiding Symptoms
NCT02078895
A Pilot Study Non-Invasive Guidance for Therapeutic Ultrasound Treatment of Lower Back Muscle Injuries
NCT02169726
Evaluation of Goal-Directed Intraoperative Hemodynamic Optimization Protocol
NCT02057653
FINGER Robot Therapy Study
NCT02048826
Comparing Post-Op Narcotic Usage in Patients Receiving Periarticular Exparel vs. Standard Periarticular Joint Inj
NCT02682498
Measurement of Neonatal Microvascular Hemodynamics Using Non-invasive Optical Technologies
NCT01982357
MRI Temperature Mapping of the Prostate and Urogenital Pelvis Cooled by an Endorectal Balloon
NCT01979848
Novel Treatment for Port Wine Stain Birthmarks
NCT01924273
Transurethral Ultrasonic Imaging For Detection and Classification of Prostate Cancer
NCT02307552
Pathogenic Mechanisms of Port Wine Stain and Repository of Port Wine Stain Biopsy Samples
NCT02051101
Office-based Percutaneous Ultrasound-guided Renal Biopsy
NCT02075684
IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus
NCT01841619
The Use of Diffuse Optical Spectroscopy to Characterize in Response to Weight-Loss Intervention
NCT02146885
The Effect of Computerized Alcohol Screening and Brief Intervention (CASI) on Alcohol Consumption in Adolescent Patients in the Emergency Department
NCT01680627
The Efficacy of Computerized Alcohol Screening and Intervention (CASI) in At-Risk Emergency Department and Trauma Patients
NCT01680614
Evaluate the Port-wine Stain Birthmark Treatment Before and After Pulsed Dye Laser Treatment
NCT01774552
Combined Bipolar Radiofrequency&Pulsed Dye Laser Treatment
NCT01775722
Closed-Loop Fluid Administration System Using Hemodynamic Monitors
NCT02020863
Influence of Timing on Motor Learning
NCT01769326
The Natural History of Human Stingray Injuries
NCT01685749
Retapamulin for Reducing MRSA Nasal Carriage
NCT01461668
Randomized Study Comparing the Use of Epidural Analgesia to Intravenous Narcotics for Laparoscopic Colorectal Resection.
NCT02086123
Twitter-enabled Mobile Messaging for Smoking Relapse Prevention
NCT01602536
1320 nm Nd:YAG Laser for Improving the Appearance of Onychomycosis
NCT01498393
Radial Artery Access With Ultrasound Trial
NCT01605292
Development of an Algorithm for Prediction of Onset of Hemodynamic Instability in Humans
NCT00581204
Study of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant Melanoma
NCT01321437
Assessing Cerebrovascular Reactivity Based on Cerebral Oximetry: a Pilot Study
NCT01483495
RObotic Versus LAparoscopic Resection for Rectal Cancer
NCT01736072
Development and Validation of a NIRS-based Sinusitis Screening
NCT01485484
Goal Directed Fluid Management Based on Non-invasive Monitoring
NCT01883752
Healthcare Provider Behavior and Children's Perioperative Distress
NCT01878747
Test of an Intervention to Increase Physical Activity Among School Children
NCT01876602
Accuracy of Dilution of EUS-FNA Pancreatic Cyst Fluid for Carcinoembryonic Antigen (CEA) Measurement
NCT01494077
Role of Metabolic Enzymes in Non-Melanoma Skin Cancer
NCT02244749
Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis Pemphigus
NCT01313923
Project CLEAR - Changing Lives by Eradicating Antibiotic Resistance
NCT01209234
Monitoring of Tissue Transfer Flaps by Modulated Imaging (MI) Spectroscopy
NCT00633503
Monitoring Chemotherapy Response of Soft Tissue Sarcomas and Osteosarcomas Using Diffuse Optical Spectroscopic Imaging
NCT01263405
Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer Patients
NCT01882985
Study to Determine Effects of Vesicare on Return to Continence Post - Radical Prostatectomy (Part II)
NCT01215721
Diagnosis of Pancreatic Cysts: Endoscopic Ultrasound With Fine Needle Aspiration (EUS/FNA), Direct Visualization, and Confocal Laser-induced Endomicroscopy-A Pilot Study
NCT01447238
Comparison of Efficacy, Safety and Tolerability of Two Different 810 nm Diode Lasers for Hair Reduction
NCT01212172
Pazopanib and Paclitaxel as First-Line Treatment for Subjects With Unresectable Stage III and Stage IV Melanoma
NCT01107665
Noninvasive Optical Measurement of Critical Care Neonates
NCT01483703
Monitoring the Response of Port Wine Stain Birthmarks to Laser Therapy With Wide-field Functional Imaging Technologies
NCT01333553
Pain Blocking During Drug Administration or Blood Collection With Needles
NCT01166906
Customized Acoustic Stimulation for the Treatment of Tinnitus
NCT01487447
Effects of a High Protein Diet on Clinical Outcomes in Heart Failure
NCT01423266
A Pilot Study Using Photo-plethysmographic (PPG) Camera
NCT01166867
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 46 |
| Phase 2 | 46 |
| Phase 3 | 6 |
| Phase 4 | 21 |
Therapeutic Areas
What is open in the University of California, Irvine pipeline
74 recruiting of 368 indexed (20% open); 228 completed (62%).
Phase mix: 27 late (III/IV) vs 92 early (I/II) (early-phase heavy).
Top condition: Cancer (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, Irvine: open-pipeline peers nationwide
Peers matched on 368 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
University of California, Irvine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 368 trials (± recruiting share)
- Northwell Health · 370 trials · 22% recruiting
- UNC Lineberger Comprehensive Cancer Center · 366 trials · 22% recruiting
- Roswell Park Cancer Institute · 365 trials · 16% recruiting
- New York State Psychiatric Institute · 364 trials · 3% recruiting
Sponsors near 20% open enrollment (± trial volume)
- University of Miami · 20% recruiting · 721 trials
- Endeavor Health · 20% recruiting · 94 trials
- Acera Surgical · 20% recruiting · 5 trials
- Align Technology · 20% recruiting · 5 trials
Related
What to do with this University of California, Irvine page
368 registered trials is a research-attention snapshot, not an endorsement of University of California, Irvine or any single study.
- 74 of University of California, Irvine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Cancer is the condition University of California, Irvine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, Irvine pipeline card: 368 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.